177 Lu-labeled PSMA-617 is a promising new therapeutic agent for radioligand therapy (RLT)
of patients with metastatic castration-resistant prostate cancer (mCRPC). Initiated by the …

In 2004, we reported a novel method of repairing a human mandible by in vivo tissue
engineering. The patient served as his own bioreactor as the exogenously prepared customized …

Regulatory macrophages (M regs) were administered to two living-donor renal transplant
recipients. Both patients were minimized to low-dose tacrolimus monotherapy within 24 wk of …

Objective Vedolizumab, a monoclonal antibody directed against the integrin heterodimer
α4β7, is approved for the treatment of Crohn’s disease and ulcerative colitis. The efficacy of …

Purpose To compare unenhanced lung ventilation-weighted (VW) and perfusion-weighted (QW)
imaging based on Fourier decomposition (FD) magnetic resonance (MR) imaging with …

Reconstruction of critical-size jaw defects still remains challenging. The standard treatment
today is transplantation of autologous bone grafts, which is associated with high donor-site …

The present study elucidates the neuroprotective mechanisms of the PPARγ (peroxisome
proliferator-activated receptor γ) agonist pioglitazone in survival of ischemic neurons following …

Background The recent development of quinoline-based radiotracers, which act as
fibroblast activation protein inhibitors (FAPIs), has shown promising preclinical and clinical …

Inflammation is a strong driver of atherosclerotic cardiovascular disease (ASCVD). There is
a large unmet need for therapies that prevent or reduce excessive inflammation while …

Background Sentinel lymph node (SLN) biopsy represents a well-established diagnostic tool
for the assessment of lymphatic metastasis. Correct pre- and intraoperative visualization of …